# Tryptophan Metabolism in Neurodevelopment and Its Implications For Neurodevelopmental Disorders

**Authors:** Maria Grazia Giuliano, Paola Tognini

PMC · DOI: 10.1007/s12035-025-05437-9 · 2025-11-20

## TL;DR

This paper reviews how tryptophan metabolism affects brain development and how its disruption may contribute to neurodevelopmental disorders.

## Contribution

The paper systematically explores the underexplored role of tryptophan metabolism in neurodevelopmental disorders.

## Key findings

- Tryptophan metabolism is crucial for brain maturation and immune regulation.
- Disruption in tryptophan metabolism is linked to autism spectrum disorder and attention-deficit/hyperactivity disorder.
- The kynurenine pathway and gut microbiota-derived indoles are key in neurodevelopmental processes.

## Abstract

The role of tryptophan metabolism has been recognized in a wide range of physiological and pathological processes but is still only partially understood. Growing evidence highlights the importance of maintaining tryptophan homeostasis throughout life, with its disruption now linked to various neuropsychiatric conditions spanning from early life to aging. While it is increasingly evident that alterations in tryptophan metabolism have significant implications for both neurodevelopmental and neurodegenerative disorders, research has predominantly focused on the latter, leaving neurodevelopmental aspects comparatively underexplored. This review provides a comprehensive overview of both preclinical and clinical studies, highlighting the intricate relationship between tryptophan metabolism and neurodevelopment. Particular focus is given to the kynurenine pathway and gut microbiota-derived indole production, two interconnected metabolic branches with profound effects on brain maturation, plasticity, and immune regulation. Finally, we examine the pathophysiological consequences of tryptophan dysregulation in neurodevelopmental disorders, including autism spectrum disorder, attention-deficit/hyperactivity disorder, and Rett syndrome. We also discuss potential therapeutic strategies targeting tryptophan metabolism in these conditions.

## Linked entities

- **Chemicals:** tryptophan (PubChem CID 1148)
- **Diseases:** autism spectrum disorder (MONDO:0005258), attention-deficit/hyperactivity disorder (MONDO:0007743), Rett syndrome (MONDO:0010726)

## Full-text entities

- **Diseases:** Rett syndrome (MESH:D015518), neurodevelopmental and neurodegenerative disorders (MESH:D019636), attention-deficit/hyperactivity disorder (MESH:D001289), Neurodevelopmental Disorders (MESH:D002658), neuropsychiatric conditions (MESH:D001523), autism spectrum disorder (MESH:D000067877)
- **Chemicals:** Tryptophan (MESH:D014364), kynurenine (MESH:D007737), indole (MESH:C030374)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12630162/full.md

---
Source: https://tomesphere.com/paper/PMC12630162